Article Details
Retrieved on: 2025-09-09 13:15:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Company has advanced this highly potent monoclonal antibody into separate Phase 2 trials for the treatment of chronic rhinosinusitis with ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here